Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NK Investor Alert: Glancy Prongay & Murray LLP Commences Investigation on Behalf of NantKwest, Inc. Investors

IBRX

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of investors of NantKwest, Inc. (“NantKwest” or the “Company”) (NASDAQ: NK) concerning the Company and its officers’ possible violations of federal securities laws in connection with alleged accounting errors in the Company’s financial statements. GPM is preparing a lawsuit on behalf of injured investors.

NantKwest is a biotechnology company that develops immunotherapeutic agents for various clinical conditions. The investigation concerns NantKwest’s March 11, 2016 announcement that the Company's interim financial statements, for the quarters ended June 30, 2015 and September 30, 2015, should not be relied upon due to financial statement errors in connection with certain stock-based awards. The Company also announced that NantKwest’s financial statements contained errors related to build-to-suit lease accounting.

On this news, shares of NantKwest fell over 3% on March 11, 2016, closing at just $8.17 per share.

If you purchased NantKwest securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today